The differentiation of cardiomyocytes from mouse embryonic stem cells is altered by dioxin

Tui Neri, Valeria Merico, Fabio Fiordaliso, Monica Salio, Paola Rebuzzini, Lucia Sacchi, Riccardo Bellazzi, Carlo Alberto Redi, Maurizio Zuccotti, Silvia Garagna

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

2,3,7,8-Tetrachlorodibenzo-para-dioxin (TCDD) causes abnormalities during heart development. Cardiomyocytes derived from embryonic stem (ES) cells are a robust model for the study of early cardiomyogenesis. Here, we evaluated the effects of TCDD at key stages during the differentiation of mouse ES cells into cardiomyocytes analysing: (i) the transcription of lineage differentiation (Brachyury, Nkx-2.5, Actc-1), cardiac-specific (Alpk3, cTnT, cTnI, cTnC) and detoxification phase I (Cyp1A1, Cyp1A2 and Cyp1B1) and phase II (Nqo1, Gsta1 and Ugt1a6) genes; (ii) the global gene expression; (iii) the ultrastructure of ES-derived cardiomyocytes; (iv) level of ATP production and (v) the immunolocalisation of sarcomeric α-actinin, β-myosin heavy chain and cTnT proteins. We show that TCDD affects the differentiation of ES cells into cardiomyocytes at several levels: (1) induces the expression of phase I genes; (2) down-regulates a group of heart-specific genes, some involved in the oxidative phosphorylation pathway; (3) reduces the efficiency of differentiation; (4) alters the arrangement of mitochondria, that show twisted and disrupted cristae, and of some sarcomeres, with misalignement or disarrangement of the myofibrillar organisation and (5) reduces ATP production. This study provides novel evidences that TCDD impairs cardiomyocyte differentiation. Sarcomeres and mitochondria could be a target for dioxin toxicity, their disruption representing a possible mechanism developing cardiac injury.

Original languageEnglish
Pages (from-to)226-236
Number of pages11
JournalToxicology Letters
Volume202
Issue number3
DOIs
Publication statusPublished - May 10 2011

Fingerprint

Dioxins
Stem cells
Cardiac Myocytes
Sarcomeres
Mitochondria
Genes
Embryonic Stem Cells
Phase I Metabolic Detoxication
Adenosine Triphosphate
Actinin
Detoxification
Myosin Heavy Chains
Congenital Heart Defects
Oxidative Phosphorylation
Transcription
Gene expression
Toxicity
Down-Regulation
Mouse Embryonic Stem Cells
Gene Expression

Keywords

  • Cardiomyocytes differentiation
  • Dioxin
  • Embryonic stem cells
  • Mouse
  • Myofibrils

ASJC Scopus subject areas

  • Toxicology

Cite this

The differentiation of cardiomyocytes from mouse embryonic stem cells is altered by dioxin. / Neri, Tui; Merico, Valeria; Fiordaliso, Fabio; Salio, Monica; Rebuzzini, Paola; Sacchi, Lucia; Bellazzi, Riccardo; Redi, Carlo Alberto; Zuccotti, Maurizio; Garagna, Silvia.

In: Toxicology Letters, Vol. 202, No. 3, 10.05.2011, p. 226-236.

Research output: Contribution to journalArticle

Neri, Tui ; Merico, Valeria ; Fiordaliso, Fabio ; Salio, Monica ; Rebuzzini, Paola ; Sacchi, Lucia ; Bellazzi, Riccardo ; Redi, Carlo Alberto ; Zuccotti, Maurizio ; Garagna, Silvia. / The differentiation of cardiomyocytes from mouse embryonic stem cells is altered by dioxin. In: Toxicology Letters. 2011 ; Vol. 202, No. 3. pp. 226-236.
@article{11d36433b19b43f9be78afe5bdd48f1c,
title = "The differentiation of cardiomyocytes from mouse embryonic stem cells is altered by dioxin",
abstract = "2,3,7,8-Tetrachlorodibenzo-para-dioxin (TCDD) causes abnormalities during heart development. Cardiomyocytes derived from embryonic stem (ES) cells are a robust model for the study of early cardiomyogenesis. Here, we evaluated the effects of TCDD at key stages during the differentiation of mouse ES cells into cardiomyocytes analysing: (i) the transcription of lineage differentiation (Brachyury, Nkx-2.5, Actc-1), cardiac-specific (Alpk3, cTnT, cTnI, cTnC) and detoxification phase I (Cyp1A1, Cyp1A2 and Cyp1B1) and phase II (Nqo1, Gsta1 and Ugt1a6) genes; (ii) the global gene expression; (iii) the ultrastructure of ES-derived cardiomyocytes; (iv) level of ATP production and (v) the immunolocalisation of sarcomeric α-actinin, β-myosin heavy chain and cTnT proteins. We show that TCDD affects the differentiation of ES cells into cardiomyocytes at several levels: (1) induces the expression of phase I genes; (2) down-regulates a group of heart-specific genes, some involved in the oxidative phosphorylation pathway; (3) reduces the efficiency of differentiation; (4) alters the arrangement of mitochondria, that show twisted and disrupted cristae, and of some sarcomeres, with misalignement or disarrangement of the myofibrillar organisation and (5) reduces ATP production. This study provides novel evidences that TCDD impairs cardiomyocyte differentiation. Sarcomeres and mitochondria could be a target for dioxin toxicity, their disruption representing a possible mechanism developing cardiac injury.",
keywords = "Cardiomyocytes differentiation, Dioxin, Embryonic stem cells, Mouse, Myofibrils",
author = "Tui Neri and Valeria Merico and Fabio Fiordaliso and Monica Salio and Paola Rebuzzini and Lucia Sacchi and Riccardo Bellazzi and Redi, {Carlo Alberto} and Maurizio Zuccotti and Silvia Garagna",
year = "2011",
month = "5",
day = "10",
doi = "10.1016/j.toxlet.2011.02.008",
language = "English",
volume = "202",
pages = "226--236",
journal = "Toxicology Letters",
issn = "0378-4274",
publisher = "Elsevier BV",
number = "3",

}

TY - JOUR

T1 - The differentiation of cardiomyocytes from mouse embryonic stem cells is altered by dioxin

AU - Neri, Tui

AU - Merico, Valeria

AU - Fiordaliso, Fabio

AU - Salio, Monica

AU - Rebuzzini, Paola

AU - Sacchi, Lucia

AU - Bellazzi, Riccardo

AU - Redi, Carlo Alberto

AU - Zuccotti, Maurizio

AU - Garagna, Silvia

PY - 2011/5/10

Y1 - 2011/5/10

N2 - 2,3,7,8-Tetrachlorodibenzo-para-dioxin (TCDD) causes abnormalities during heart development. Cardiomyocytes derived from embryonic stem (ES) cells are a robust model for the study of early cardiomyogenesis. Here, we evaluated the effects of TCDD at key stages during the differentiation of mouse ES cells into cardiomyocytes analysing: (i) the transcription of lineage differentiation (Brachyury, Nkx-2.5, Actc-1), cardiac-specific (Alpk3, cTnT, cTnI, cTnC) and detoxification phase I (Cyp1A1, Cyp1A2 and Cyp1B1) and phase II (Nqo1, Gsta1 and Ugt1a6) genes; (ii) the global gene expression; (iii) the ultrastructure of ES-derived cardiomyocytes; (iv) level of ATP production and (v) the immunolocalisation of sarcomeric α-actinin, β-myosin heavy chain and cTnT proteins. We show that TCDD affects the differentiation of ES cells into cardiomyocytes at several levels: (1) induces the expression of phase I genes; (2) down-regulates a group of heart-specific genes, some involved in the oxidative phosphorylation pathway; (3) reduces the efficiency of differentiation; (4) alters the arrangement of mitochondria, that show twisted and disrupted cristae, and of some sarcomeres, with misalignement or disarrangement of the myofibrillar organisation and (5) reduces ATP production. This study provides novel evidences that TCDD impairs cardiomyocyte differentiation. Sarcomeres and mitochondria could be a target for dioxin toxicity, their disruption representing a possible mechanism developing cardiac injury.

AB - 2,3,7,8-Tetrachlorodibenzo-para-dioxin (TCDD) causes abnormalities during heart development. Cardiomyocytes derived from embryonic stem (ES) cells are a robust model for the study of early cardiomyogenesis. Here, we evaluated the effects of TCDD at key stages during the differentiation of mouse ES cells into cardiomyocytes analysing: (i) the transcription of lineage differentiation (Brachyury, Nkx-2.5, Actc-1), cardiac-specific (Alpk3, cTnT, cTnI, cTnC) and detoxification phase I (Cyp1A1, Cyp1A2 and Cyp1B1) and phase II (Nqo1, Gsta1 and Ugt1a6) genes; (ii) the global gene expression; (iii) the ultrastructure of ES-derived cardiomyocytes; (iv) level of ATP production and (v) the immunolocalisation of sarcomeric α-actinin, β-myosin heavy chain and cTnT proteins. We show that TCDD affects the differentiation of ES cells into cardiomyocytes at several levels: (1) induces the expression of phase I genes; (2) down-regulates a group of heart-specific genes, some involved in the oxidative phosphorylation pathway; (3) reduces the efficiency of differentiation; (4) alters the arrangement of mitochondria, that show twisted and disrupted cristae, and of some sarcomeres, with misalignement or disarrangement of the myofibrillar organisation and (5) reduces ATP production. This study provides novel evidences that TCDD impairs cardiomyocyte differentiation. Sarcomeres and mitochondria could be a target for dioxin toxicity, their disruption representing a possible mechanism developing cardiac injury.

KW - Cardiomyocytes differentiation

KW - Dioxin

KW - Embryonic stem cells

KW - Mouse

KW - Myofibrils

UR - http://www.scopus.com/inward/record.url?scp=79954572856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79954572856&partnerID=8YFLogxK

U2 - 10.1016/j.toxlet.2011.02.008

DO - 10.1016/j.toxlet.2011.02.008

M3 - Article

C2 - 21354282

AN - SCOPUS:79954572856

VL - 202

SP - 226

EP - 236

JO - Toxicology Letters

JF - Toxicology Letters

SN - 0378-4274

IS - 3

ER -